What other stocks do shareholders of SciClone Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SciClone Pharmaceuticals investors own include (ONCYF) (ONCYF) , Gilead Sciences (GILD) , Novavax (NVAX) , Progenics Pharmaceuticals (PGNX) , Rite Aid (RAD) , Skyworks Solutions (SWKS) , Agenus (AGEN) , Array Technologies (ARRY) , Avid Bioservices (CDMO) and Imunon (CLSN) .

NASDAQ:SCLN

SciClone Pharmaceuticals (SCLN) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free SCLN Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $11.15
▼
$11.15
50-Day Range: N/A
52-Week Range: $8.55
▼
$11.43

Volume: N/A
Average Volume: 444,833 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get SciClone Pharmaceuticals alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About SciClone Pharmaceuticals Stock (NASDAQ:SCLN)

SciClone Pharmaceuticals, Inc. is a pharmaceutical company. The Company's product portfolio of therapies includes oncology, infectious diseases and cardiovascular disorders. The Company's business is focused primarily in the People's Republic of China. The Company operates in two segments: China and the Rest of the World, including its operations in the United States and Hong Kong. The Company's lead product ZADAXIN (thymalfasin) is approved in over 30 countries, which is used for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), and certain cancers according to the local regulatory approvals, and for use as an immune system enhancer. In addition to ZADAXIN, SciClone markets seven partnered and in-licensed products in China. The Company sells ZADAXIN in various international markets through its subsidiary, SciClone Pharmaceuticals International Ltd. (SPIL). Its development portfolio includes Angiomax, Loramyc, Neucardin, VIBATIV and Cleviprex.

Ad Crypto 101 Media

SHOCKING Crypto Leak…

Claim your free seat by clicking here now.

SCLN Stock News Headlines

December 27, 2023 | morningstar.com

SciClone Pharmaceuticals (Holdings) Ltd

April 5, 2023 | thestreet.com

SciClone Reaches New 52-Week High (SCLN)

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

February 27, 2023 | finance.yahoo.com

Dawn Health partners with leading pharmaceutical company to transform chronic care

February 9, 2023 | finance.yahoo.com

SciClone Pharmaceuticals (Holdings) Limited (6600.HK)

See More Headlines

Receive SCLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SciClone Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: Pharmaceuticals
Current Symbol: NASDAQ:SCLN
CUSIP: 80862K10
CIK: 880771
Web: www.sciclone.com
Phone: +1-650-3583456
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Jon S Saxe
Independent Chairman of the Board
Friedhelm Blobel Ph.D.
President, Chief Executive Officer, Director
Wilson W. Cheung
Chief Financial Officer, Senior Vice President - Finance, Secretary
Hong Zhao
Chief Executive Officer - China Operations
Raymond Anthony Low CPA
Vice President - Finance, Controller
Lan Xie CPA
Vice President - Finance, China Chief Financial Officer
Nancy T. Chang Ph.D.
Independent Director
Richard James Hawkins
Independent Director
Anthony Gregg Lapointe
Independent Director
Simon Li
Independent Director

SCLN Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of SciClone Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other SciClone Pharmaceuticals investors own include (ONCYF) (ONCYF), Gilead Sciences (GILD), Novavax (NVAX), Progenics Pharmaceuticals (PGNX), Rite Aid (RAD), Skyworks Solutions (SWKS), Agenus (AGEN), Array Technologies (ARRY), Avid Bioservices (CDMO) and Imunon (CLSN).

This page (NASDAQ:SCLN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

SciClone Pharmaceuticals (SCLN) Stock Price, News & Analysis

About SciClone Pharmaceuticals Stock (NASDAQ:SCLN)

SCLN Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

SCLN Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info